Related Experiment Video
Updated: Aug 7, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells
A Rodríguez-Barbero1, F Dorado, S Velasco
1Departamento de Fisiología y Farmacología, Instituto Reina Sofía de Investigación Nefrológica, Universidad de Salamanca, Campus Miguel de Unamuno, Edificio Departamental, Salamanca, Spain.
Abstract:
Transforming growth factor-beta1 (TGF-beta1) plays a fundamental role in the progression of renal diseases. Accumulating evidence has suggested that eicosanoids derived from cyclooxygenase-2 (COX-2) participate in a number of pathological processes in immune-mediated renal diseases. Mesangial cells (MC) play a major role in physiological and pathophysiological renal processes. MC express receptors for TGF-beta1, and COX-2 expression can be induced in MC. However, to date, there are no published data on the possible role of TGF-beta1 in COX-2 expression in human mesangial cells (HMC). We designed studies to determine (1) whether TGF-beta1 stimulates COX-2 expression in primary HMC, (2) whether mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) cascades are involved in TGF-beta1-induced COX-2 expression, and (3) whether prostaglandin (PG)E2 synthesis is affected by TGF-beta1 and MAP kinases and PI3K activation. Studies were performed in primary cultures of HMC and in an immortalized line of HMC. TGF-beta1 induces COX-2 promoter activity and COX-2 mRNA and protein expression in HMC. COX-2 induction is accompanied by increased PGE2 synthesis. Extracellular signal-regulated kinase (ERK)1/2, p38 MAPK, and PI3K pathway inhibition blunted TGF-beta1-induced COX-2 overexpression. We demonstrate that TGF-beta1 regulates COX-2 expression in HMC through the activation of ERK1/2, p38 MAPK, and PI3K. These results can help to elucidate the molecular mechanisms underlying the regulation of COX-2 and open up specific strategies for the treatment of glomerular disease.
Insights
Transforming growth factor-beta1 (TGF-beta1) activates cyclooxygenase-2 (COX-2) in human mesangial cells, increasing prostaglandin E2. This pathway involves mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling, offering new therapeutic targets for kidney diseases.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Transforming growth factor-beta1 (TGF-beta1) is implicated in renal disease progression.
- Eicosanoids from cyclooxygenase-2 (COX-2) are involved in immune-mediated renal pathologies.
- Mesangial cells (MC) are key players in kidney function and disease, expressing TGF-beta1 receptors and inducible COX-2.
Purpose of the Study:
- To investigate if TGF-beta1 stimulates COX-2 expression in human mesangial cells (HMC).
- To determine the involvement of mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) cascades in TGF-beta1-induced COX-2 expression.
- To assess the impact of TGF-beta1 and these signaling pathways on prostaglandin E2 (PGE2) synthesis.
Main Methods:
- Primary cultures and an immortalized cell line of HMC were utilized.
- Studies involved assessing COX-2 promoter activity, mRNA, and protein expression.
- Involvement of signaling pathways was analyzed using pathway inhibitors.
Main Results:
- TGF-beta1 significantly induced COX-2 promoter activity, mRNA, and protein expression in HMC.
- TGF-beta1-induced COX-2 expression was associated with increased PGE2 synthesis.
- Inhibition of extracellular signal-regulated kinase (ERK)1/2, p38 MAPK, and PI3K pathways attenuated TGF-beta1-induced COX-2 overexpression.
Conclusions:
- TGF-beta1 regulates COX-2 expression in HMC via activation of ERK1/2, p38 MAPK, and PI3K signaling pathways.
- This molecular mechanism highlights a novel role for TGF-beta1 in controlling COX-2 and PGE2 production in mesangial cells.
- Understanding this pathway provides insights for developing targeted therapies for glomerular diseases.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
Activation and Inactivation of G Proteins
Regulation of Angiogenesis and Blood Supply
Cell Specific Gene Expression
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

